(BCS) Barclays - Ratings and Ratios
Retail Banking, Credit Cards, Investment Banking, Wealth Management, Lending
EPS (Earnings per Share)
Revenue
| Risk via 10d forecast | |
|---|---|
| Volatility | 32.1% |
| Value at Risk 5%th | 54.0% |
| Relative Tail Risk | 2.48% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.55 |
| Alpha | 53.52 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.378 |
| Beta | 1.102 |
| Beta Downside | 1.202 |
| Drawdowns 3y | |
|---|---|
| Max DD | 29.96% |
| Mean DD | 6.99% |
| Median DD | 3.57% |
Description: BCS Barclays September 26, 2025
Barclays PLC (NYSE: BCS) is a globally diversified financial services firm headquartered in London, operating across retail, corporate, private, and investment banking, as well as wealth and investment management, with a presence in Europe, the Americas, Africa, the Middle East, and Asia.
The business is structured into five operating segments: Barclays UK, Barclays UK Corporate Bank, Barclays Private Bank & Wealth Management, Barclays Investment Bank, and Barclays US Consumer Bank, each delivering a mix of deposit-taking, lending, advisory, and securities-trading services.
Key recent performance metrics (as of FY 2023) include a CET1 capital ratio of 13.5 % (well above the 10.5 % regulatory minimum), a net interest margin of 2.2 % reflecting a higher-for-longer rate environment, and a return on equity (ROE) of 7.8 %, indicating modest profitability relative to peers.
Sector drivers that materially affect Barclays are the trajectory of central-bank policy rates (especially the Bank of England’s stance on inflation), the pace of digital-banking adoption which can compress costs but requires sustained technology investment, and regulatory capital requirements that influence dividend policy and share-buyback capacity.
Assuming the current macro backdrop of elevated rates persists, Barclays’ net interest income should remain a primary earnings catalyst, while credit-risk metrics will need close monitoring given potential stress in the UK commercial-property market.
For a deeper, data-rich assessment of how these factors translate into valuation outlooks, you might find ValueRay’s analyst dashboards useful for drilling into scenario-based forecasts.
BCS Stock Overview
| Market Cap in USD | 77,285m |
| Sub-Industry | Diversified Banks |
| IPO / Inception | 1986-09-10 |
| Return 12m vs S&P 500 | 43.7% |
| Analyst Rating | 4.0 of 5 |
BCS Dividends
| Metric | Value |
|---|---|
| Dividend Yield | 2.06% |
| Yield on Cost 5y | 7.05% |
| Yield CAGR 5y | 7.46% |
| Payout Consistency | 89.1% |
| Payout Ratio | 21.1% |
BCS Growth Ratios
| Metric | Value |
|---|---|
| CAGR 3y | 46.69% |
| CAGR/Max DD Calmar Ratio | 1.56 |
| CAGR/Mean DD Pain Ratio | 6.68 |
| Current Volume | 7132.2k |
| Average Volume | 5739.4k |
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income (6.91b TTM) > 0 and > 6% of Revenue (6% = 2.34b TTM) |
| FCFTA 0.00 (>2.0%) and ΔFCFTA 0.51pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -566.7% (prev -838.4%; Δ 271.7pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.02 (>3.0%) and CFO 27.41b > Net Income 6.91b (YES >=105%, WARN >=100%) |
| Net Debt (-252.57b) to EBITDA (9.53b) ratio: -26.49 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.80 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (3.51b) change vs 12m ago -4.12% (target <= -2.0% for YES) |
| Gross Margin 34.90% (prev -36.59%; Δ 71.49pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 2.47% (prev 1.57%; Δ 0.90pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -0.01 (EBITDA TTM 9.53b / Interest Expense TTM 25.39b) >= 6 (WARN >= 3) |
Altman Z'' -0.72
| (A) -0.14 = (Total Current Assets 867.76b - Total Current Liabilities 1088.80b) / Total Assets 1629.15b |
| (B) 0.04 = Retained Earnings (Balance) 58.37b / Total Assets 1629.15b |
| (C) -0.00 = EBIT TTM -219.0m / Avg Total Assets 1580.14b |
| (D) 0.05 = Book Value of Equity 76.39b / Total Liabilities 1552.31b |
| Total Rating: -0.72 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 48.98
| 1. Piotroski 4.0pt = -1.0 |
| 2. FCF Yield -0.83% = -0.42 |
| 3. FCF Margin 14.20% = 3.55 |
| 4. Debt/Equity 1.88 = 0.94 |
| 5. Debt/Ebitda -26.49 = 2.50 |
| 6. ROIC - WACC (= -13.33)% = -12.50 |
| 7. RoE 9.25% = 0.77 |
| 8. Rev. Trend 51.44% = 3.86 |
| 9. EPS Trend 25.42% = 1.27 |
What is the price of BCS shares?
Over the past week, the price has changed by -4.91%, over one month by +7.49%, over three months by +3.94% and over the past year by +63.20%.
Is BCS a buy, sell or hold?
- Strong Buy: 1
- Buy: 0
- Hold: 1
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the BCS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 21.7 | 2.7% |
| Analysts Target Price | 21.7 | 2.7% |
| ValueRay Target Price | 28.8 | 36.7% |
BCS Fundamental Data Overview November 12, 2025
P/E Trailing = 10.3785
P/E Forward = 7.9936
P/S = 2.9707
P/B = 0.7688
P/EG = 1.2108
Beta = 0.911
Revenue TTM = 39.00b GBP
EBIT TTM = -219.0m GBP
EBITDA TTM = 9.53b GBP
Long Term Debt = 74.96b GBP (from longTermDebt, last fiscal year)
Short Term Debt = 35.40b GBP (from shortTermDebt, last quarter)
Debt = 143.98b GBP (from shortLongTermDebtTotal, last quarter)
Net Debt = -252.57b GBP (from netDebt column, last quarter)
Enterprise Value = -664.82b GBP (58.74b + Debt 143.98b - CCE 867.54b)
Interest Coverage Ratio = -0.01 (Ebit TTM -219.0m / Interest Expense TTM 25.39b)
FCF Yield = -0.83% (FCF TTM 5.54b / Enterprise Value -664.82b)
FCF Margin = 14.20% (FCF TTM 5.54b / Revenue TTM 39.00b)
Net Margin = 17.72% (Net Income TTM 6.91b / Revenue TTM 39.00b)
Gross Margin = 34.90% ((Revenue TTM 39.00b - Cost of Revenue TTM 25.39b) / Revenue TTM)
Gross Margin QoQ = 100.0% (prev 100.0%)
Tobins Q-Ratio = -0.41 (set to none) (Enterprise Value -664.82b / Total Assets 1629.15b)
Interest Expense / Debt = 17.63% (Interest Expense 25.39b / Debt 143.98b)
Taxrate = 17.57% (365.0m / 2.08b)
NOPAT = -180.5m (EBIT -219.0m * (1 - 17.57%)) [loss with tax shield]
Current Ratio = 0.80 (Total Current Assets 867.76b / Total Current Liabilities 1088.80b)
Debt / Equity = 1.88 (Debt 143.98b / totalStockholderEquity, last quarter 76.39b)
Debt / EBITDA = -26.49 (Net Debt -252.57b / EBITDA 9.53b)
Debt / FCF = -45.60 (Net Debt -252.57b / FCF TTM 5.54b)
Total Stockholder Equity = 74.75b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.42% (Net Income 6.91b / Total Assets 1629.15b)
RoE = 9.25% (Net Income TTM 6.91b / Total Stockholder Equity 74.75b)
RoCE = -0.15% (EBIT -219.0m / Capital Employed (Equity 74.75b + L.T.Debt 74.96b))
RoIC = -0.09% (negative operating profit) (NOPAT -180.5m / Invested Capital 208.25b)
WACC = 13.24% (E(58.74b)/V(202.72b) * Re(10.08%) + D(143.98b)/V(202.72b) * Rd(17.63%) * (1-Tc(0.18)))
Discount Rate = 10.08% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -51.77%
[DCF Debug] Terminal Value 61.85% ; FCFE base≈5.54b ; Y1≈3.64b ; Y5≈1.66b
Fair Price DCF = 6.95 (DCF Value 24.20b / Shares Outstanding 3.48b; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: 25.42 | EPS CAGR: 23.46% | SUE: -0.54 | # QB: 0
Revenue Correlation: 51.44 | Revenue CAGR: 8.05% | SUE: 0.02 | # QB: 0
Additional Sources for BCS Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle